Bachem Expands Corporate Executive Committee to Include Chief Operations Officer Role
Bachem (OTC:BCHMY) has announced the appointment of Hans Van Hees as Chief Operations Officer (COO), effective September 1, 2025. Van Hees, currently serving as COO Europe, will join the Corporate Executive Committee and oversee Bachem's worldwide manufacturing network.
Van Hees joined Bachem in 2024 from Pharma Resource Group and brings over 25 years of manufacturing leadership experience from Johnson & Johnson and Janssen. He will take over the COO responsibilities from CEO Thomas Meier, who had been handling both roles since 2023. The new COO holds a PhD in Chemistry and an MBA from KU Leuven.
Bachem (OTC:BCHMY) ha annunciato la nomina di Hans Van Hees a Chief Operations Officer (COO), con decorrenza dal 1° settembre 2025. Van Hees, attualmente COO per l'Europa, entrerà a far parte del Corporate Executive Committee e avrà la responsabilità della rete produttiva globale di Bachem.
Van Hees è entrato in Bachem nel 2024 proveniente da Pharma Resource Group e vanta oltre 25 anni di esperienza nella leadership della produzione maturata in Johnson & Johnson e Janssen. Assumerà le responsabilità di COO che finora erano state gestite dal CEO Thomas Meier, che ricopriva entrambi i ruoli dal 2023. Il nuovo COO è in possesso di un dottorato in Chimica e di un MBA conseguito presso la KU Leuven.
Bachem (OTC:BCHMY) ha anunciado el nombramiento de Hans Van Hees como Chief Operations Officer (COO), con vigencia a partir del 1 de septiembre de 2025. Van Hees, que actualmente es COO para Europa, se incorporará al Corporate Executive Committee y supervisará la red de producción mundial de Bachem.
Van Hees se unió a Bachem en 2024 procedente de Pharma Resource Group y aporta más de 25 años de experiencia en liderazgo en manufacturing adquirida en Johnson & Johnson y Janssen. Asumirá las responsabilidades de COO que hasta ahora estaban en manos del CEO Thomas Meier, quien desempeñaba ambos cargos desde 2023. El nuevo COO tiene un doctorado en Química y un MBA por la KU Leuven.
Bachem (OTC:BCHMY)는 2025년 9월 1일부로 Hans Van Hees를 최고운영책임자(COO)로 임명했다고 발표했습니다. 현재 유럽 COO를 맡고 있는 Van Hees는 기업 집행 위원회(Corporate Executive Committee)에 합류해 Bachem의 전 세계 생산 네트워크를 총괄합니다.
Van Hees는 2024년 Pharma Resource Group에서 Bachem에 합류했으며 Johnson & Johnson과 Janssen에서의 경력을 포함해 25년 이상의 제조 리더십 경험을 보유하고 있습니다. 그는 2023년부터 두 직책을 병행해온 CEO 토마스 마이어(Thomas Meier)로부터 COO 업무를 인수합니다. 신임 COO는 화학 박사 학위와 KU Leuven의 MBA를 소지하고 있습니다.
Bachem (OTC:BCHMY) a annoncé la nomination de Hans Van Hees au poste de Chief Operations Officer (COO), à compter du 1er septembre 2025. Van Hees, actuellement COO pour l'Europe, rejoindra le Corporate Executive Committee et supervisera le réseau de production mondial de Bachem.
Van Hees a rejoint Bachem en 2024 en provenance de Pharma Resource Group et apporte plus de 25 ans d'expérience en management de la production acquise chez Johnson & Johnson et Janssen. Il reprendra les fonctions de COO jusque-là assumées par le CEO Thomas Meier, qui cumulait les deux rôles depuis 2023. Le nouveau COO est titulaire d'un doctorat en chimie et d'un MBA de la KU Leuven.
Bachem (OTC:BCHMY) hat die Ernennung von Hans Van Hees zum Chief Operations Officer (COO) mit Wirkung zum 1. September 2025 bekannt gegeben. Van Hees, derzeit COO für Europa, wird dem Corporate Executive Committee beitreten und Bachems weltweites Produktionsnetzwerk leiten.
Van Hees kam 2024 von der Pharma Resource Group zu Bachem und bringt über 25 Jahre Führungserfahrung in der Produktion aus Stationen bei Johnson & Johnson und Janssen mit. Er übernimmt die COO-Aufgaben von CEO Thomas Meier, der beide Rollen seit 2023 innehatte. Der neue COO besitzt einen Doktortitel in Chemie und einen MBA der KU Leuven.
- Appointment of experienced leader with 25+ years in manufacturing leadership
- Separation of CEO and COO roles allows better focus on respective responsibilities
- New COO brings valuable expertise from major pharmaceutical companies
- None.
Bubendorf, Switzerland--(Newsfile Corp. - August 20, 2025) - The Bachem Group (SIX: BANB) announced today that Hans Van Hees, currently Chief Operations Officer Europe, will take on the role of Chief Operations Officer (COO) and join the Corporate Executive Committee (CEC) as of September 1, 2025. In this role, he will report to the CEO of Bachem, Thomas Meier, and will lead Bachem’s worldwide manufacturing network. Thomas Meier, who, in addition to his role as CEO, had also taken on the duties of the COO in 2023, will hand these over accordingly.
Kuno Sommer, Chairman of Bachem's Board of Directors said:
"I am glad that Hans Van Hees, a respected leader with many years of experience in large-scale manufacturing, will take on the role of Chief Operations Officer and ensure the further development of our production network. I thank Thomas Meier for taking on additional duties as COO during a very relevant period for Bachem. His efforts over the past two years have allowed for important changes in the operation of our production network and key capacity expansions.”
Hans Van Hees joined Bachem in 2024 as COO Europe from Pharma Resource Group. Formerly, he served for more than 25 years in various manufacturing leadership roles at Johnson & Johnson and Janssen, including VP of Small Molecule API cluster at Janssen and VP of Global Technical Operations at Johnson & Johnson Consumer Health. He holds a Master’s degree and a PhD in Chemistry, as well as an MBA from KU Leuven.
About Bachem
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with its headquarters in Switzerland and sites in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.
| For more information | |
| Media Dr. Daniel Grotzky | Investors Barbora Blaha |
This publication may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Bachem Holding AG and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Bachem Holding AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or de
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263195
FAQ
Who is the new Chief Operations Officer (COO) of Bachem?
What is Hans Van Hees' background before joining Bachem?
Why is Bachem appointing a new COO in 2025?
What are Hans Van Hees' educational qualifications?
